Skip to main content

Table 4 Treatment

From: COVID-19 related multisystem inflammatory syndrome in children (MIS-C): a case series from a tertiary care pediatric hospital in Qatar

 

Case-1

Case-2

Case-3

Case-4

Case-5

Case-6

Case-7

Summary

IVIG

2 g/kg;

1 dose

1 g/kg;

1 dose

2 g/kg;

2 dose

1.5 g/kg;

1 dose

2 g/kg;

1 dose

2 g/kg;

2 dose

2 g/kg;

2 dose

100%

aCorticosteroids

Prednisolone (2 mg/kg/D;1 M)

Prednisolone (2 mg/kg/D; 2 W)

None

Methylprednisolone (30 mg/kg/D; 3D)

Prednisolone (1 mg/kg/day; 1 M)

Methylprednisolone (30 mg/kg/D; 1 dose)

Prednisolone

2 mg/kg/day; 6 W)

Methylprednisolone (30 mg/kg/D; 3D)

Prednisolone

2 mg/kg/day; 3 M)

Prednisolone (2 mg/kg/D; 3 M)

85.7%

Antibiotics

FEP (2D)

MEM (5D) VAN(3D) AMC (7D)

CRO (7D)

CLI (7D)

CRO (5D)

CRO (3D)

MTZ (4D)

MEM (1D)

TZP (5D)

CRO (2D)

None

100%

Anticoagulants

Enoxaparin

(2 mg/kg/D;

3D)

Enoxaparin

(2 mg/kg/D;

15D)

None

Enoxaparin

(2 mg/kg/D;

15D)

Enoxaparin

(1 mg/kg/D;

4D)

Enoxaparin

(1 mg/kg;

2 dose)

Enoxaparin

(2 mg/kg/D; 6 M) Clopidogrel (10 mg/D; 6 M)

Warfarin

(2 mg/cont.)

85.7%

Epinephrine/ norepinephrine

EPI (0.1 μg/kg/min, 2D)

N-EPI (0.1 μg/kg/min, 4D)

N-EPI (0.15 μg/kg/min, 2D)

None

N-EPI

(0.05 μg/kg/min, 4D)

None

N-EPI (0.1 μg/kg/min, 1D)

None

42.9%

Aspirin

4 mg/kg/D; 1 M

5 mg/kg/D; 1 M

5 mg/kg/D; 3 M

Yes

2 mg/kg/D; continued

3 mg/kg/D; 3 M

5 mg/kg/D; continued

100%

aInterleukin-1ra inhibitor

None

None

None

Anakinra

(5 mg/kg/D; 2 M)

None

None

Anakinra (4 mg/kg/D, 2 M)

28.6%

  1. aduration includes tapering
  2. M month; W week; D day; IVIG intravenous immunoglobulin; AMC amoxicillin-clavulanic acid; MEM meropenem; FEP cefepime; CRO ceftriaxone; CLI clindamycin; TZP piperacillin-tazobactam; EPI epinephrine; N-EPI norepinephrine